Brain Tumours: Pre-clinical Assessment of Targeted, SiteSpecific Therapy Exploiting Ultrasound and CancerChemotherapeutic Drugs

Anthony McHale, N Nomikou

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

Although recent advances in developingdrug carriers and targeting systems to facilitate sitedirected,cancer chemotherapy-based treatment modalitiesfor solid tumours in general have indicated verysignificant patient benefit, tumours occurring in thebrain have presented significant challenges. The purposeof this chapter will be to review existing therapeuticapplications of transcranial ultrasound and toexamine current experimental approaches based on theuse of ultrasound to non-invasively enhance the actionof cancer chemotherapeutics in a site-specific manner.Benefits afforded by such therapeutic strategies in thetreatment of localised intracranial solid tumours willbe highlighted.
LanguageEnglish
Title of host publicationTumors of the Central Nervous System, Volume 4
Pages313-322
Volume4
DOIs
Publication statusPublished - 1 Jan 2012

Fingerprint

Brain Neoplasms
Pharmaceutical Preparations
Neoplasms
Therapeutics
Drug Therapy

Cite this

@inbook{70ef906cd44d47079d4ef3ecda49bbf8,
title = "Brain Tumours: Pre-clinical Assessment of Targeted, SiteSpecific Therapy Exploiting Ultrasound and CancerChemotherapeutic Drugs",
abstract = "Although recent advances in developingdrug carriers and targeting systems to facilitate sitedirected,cancer chemotherapy-based treatment modalitiesfor solid tumours in general have indicated verysignificant patient benefit, tumours occurring in thebrain have presented significant challenges. The purposeof this chapter will be to review existing therapeuticapplications of transcranial ultrasound and toexamine current experimental approaches based on theuse of ultrasound to non-invasively enhance the actionof cancer chemotherapeutics in a site-specific manner.Benefits afforded by such therapeutic strategies in thetreatment of localised intracranial solid tumours willbe highlighted.",
author = "Anthony McHale and N Nomikou",
year = "2012",
month = "1",
day = "1",
doi = "10.1007/978-94-007-1706-0_32",
language = "English",
isbn = "978-94-007-1706-0",
volume = "4",
pages = "313--322",
booktitle = "Tumors of the Central Nervous System, Volume 4",

}

Brain Tumours: Pre-clinical Assessment of Targeted, SiteSpecific Therapy Exploiting Ultrasound and CancerChemotherapeutic Drugs. / McHale, Anthony; Nomikou, N.

Tumors of the Central Nervous System, Volume 4. Vol. 4 2012. p. 313-322.

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - Brain Tumours: Pre-clinical Assessment of Targeted, SiteSpecific Therapy Exploiting Ultrasound and CancerChemotherapeutic Drugs

AU - McHale, Anthony

AU - Nomikou, N

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Although recent advances in developingdrug carriers and targeting systems to facilitate sitedirected,cancer chemotherapy-based treatment modalitiesfor solid tumours in general have indicated verysignificant patient benefit, tumours occurring in thebrain have presented significant challenges. The purposeof this chapter will be to review existing therapeuticapplications of transcranial ultrasound and toexamine current experimental approaches based on theuse of ultrasound to non-invasively enhance the actionof cancer chemotherapeutics in a site-specific manner.Benefits afforded by such therapeutic strategies in thetreatment of localised intracranial solid tumours willbe highlighted.

AB - Although recent advances in developingdrug carriers and targeting systems to facilitate sitedirected,cancer chemotherapy-based treatment modalitiesfor solid tumours in general have indicated verysignificant patient benefit, tumours occurring in thebrain have presented significant challenges. The purposeof this chapter will be to review existing therapeuticapplications of transcranial ultrasound and toexamine current experimental approaches based on theuse of ultrasound to non-invasively enhance the actionof cancer chemotherapeutics in a site-specific manner.Benefits afforded by such therapeutic strategies in thetreatment of localised intracranial solid tumours willbe highlighted.

U2 - 10.1007/978-94-007-1706-0_32

DO - 10.1007/978-94-007-1706-0_32

M3 - Chapter

SN - 978-94-007-1706-0

VL - 4

SP - 313

EP - 322

BT - Tumors of the Central Nervous System, Volume 4

ER -